News | September 2, 2008

This Report Reveals The Findings Of The Pharmaceutical Raw Materials Manufacturing In China

DUBLIN, Ireland --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/c85704/pharmaceutical_raw) has announced the addition of the "Pharmaceutical Raw Materials Manufacturing in China" report to their offering.

The IBISWorld Pharmaceutical Raw Materials Manufacturing in China industry report is comprised of establishments primarily engaged in the manufacture of chemical medicine raw materials for further manufacture of finished pharmaceutical products. This industry is within the Chemical Pharmaceutical Manufacturing sub-sector in China, which includes the manufacture of chemical substances for pharmacy, such as bacteriophage, endocrine products, basic vitamins, sulfanilamide medicine, salicylate, glucose and alkaloids. However, hematic products are not included. This industry acts as a bridge between the upstream chemical industry and the downstream medical market, and is affected not only by the economy and trade, but also by medical insurance levels of China.

Key Topics Covered:
INDUSTRY DEFINITION

  • Industry Definition
  • Activities (Products and Services)
  • Similar Industries
  • Demand & Supply Industries

KEY STATISTICS

  • Constant Prices Table (applicable deflator applied)
  • Current Prices Table
  • Real Growth Table
  • Ratio Table
  • Statistics Available Include: Revenue, Industry Gross Product, Enterprises, Establishments, Employment, Imports, Exports, Assets, Total Wages, Domestic Demand
  • Graphs Include: Revenue, Revenue Growth Rate, Employment, Imports and Exports SEGMENTATION
  • Products and Service Segmentation
  • Major Market Segments
  • Industry Concentration
  • Geographic Spread

MARKET CHARACTERISTICS

  • Market Size
  • Linkages
  • Demand Determinants
  • Domestic and International Markets
  • Basis of Competition
  • Life Cycle

INDUSTRY CONDITIONS

  • Barriers to Entry
  • Taxation
  • Industry Assistance
  • Regulation and Deregulation
  • Cost Structure
  • Capital and Labour Intensity
  • Technology and Systems
  • Industry Volatility
  • Globalisation

KEY FACTORS

  • Key Sensitivities
  • Key Success Factors

KEY COMPETITORS

  • Major Players including Market Shares
  • Player Performance Analysis

INDUSTRY PERFORMANCE

  • Current Performance Analysis with data series and graphs
  • Historical Performance Analysis with data series and graphs OUTLOOK
  • Industry Forecast Analysis with five year forecast data series and graphs

For more information visit: http://www.researchandmarkets.com/research/c85704/pharmaceutical_raw

Copyright 2008 Business Wire All Rights Reserved